HENRY HOLETS: Open Payments
NPI 1083638043 · MONONGAHELA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,209 in 72 payments from 15 companies in 2025. Trend: 2023 $1,916 · 2024 $1,571 · 2025 $1,209
Food & beverage: $1,209
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $356 |
| GlaxoSmithKline, LLC. | 10 | $161 |
| ABBVIE INC. | 12 | $152 |
| Amgen Inc. | 10 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $92 |
| PFIZER INC. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Exact Sciences Corporation | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
Products named: TRELEGY ELLIPTA, OTEZLA, VRAYLAR, Rybelsus, Kerendia, Wegovy, Ozempic, ELIQUIS.
Industry payments across PA — which companies pay providers there.
